CAVALLARI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.820
EU - Europa 161
AS - Asia 130
SA - Sud America 1
Totale 2.112
Nazione #
US - Stati Uniti d'America 1.819
CN - Cina 122
IT - Italia 55
SE - Svezia 48
FI - Finlandia 23
GB - Regno Unito 10
UA - Ucraina 10
DE - Germania 8
IN - India 7
IE - Irlanda 6
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
JP - Giappone 1
Totale 2.112
Città #
Fairfield 333
Woodbridge 206
Ann Arbor 189
Ashburn 148
Chandler 133
Houston 132
Cambridge 113
Wilmington 101
Seattle 93
Jacksonville 54
San Diego 51
Padova 44
Beijing 39
Princeton 31
Medford 19
Nanjing 19
Boardman 18
Des Moines 16
Guangzhou 13
New York 13
Nanchang 9
Roxbury 9
Helsinki 7
Dublin 6
Shenyang 6
London 4
Changsha 3
Hangzhou 3
Phoenix 3
Redwood City 3
Tianjin 3
Borås 2
Buccinasco 2
Hebei 2
Jiaxing 2
Kunming 2
Los Angeles 2
Norwalk 2
Washington 2
Zhengzhou 2
Acton 1
Baotou 1
Camparada 1
Casale Monferrato 1
Forlì 1
Hefei 1
Hounslow 1
Jinan 1
Manaus 1
Ningbo 1
Ogden 1
Quzhou 1
Shanghai 1
Sofia 1
Taizhou 1
Tappahannock 1
Wuhan 1
Totale 1.856
Nome #
The left atrial appendage: from embryology to prevention of thromboembolism 169
Quantitative analysis of human T-lymphotropic virus type 1 (HTLV-1) gene expression using nucleo-cytoplasmic fractionation and splice junction-specific real-time RT-PCR (qRT-PCR). 121
Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma 113
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists 108
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 104
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs 100
Differential expression of menin in sporadic pituitary adenomas 95
Metabolic rewiring and redox alterations in malignant pleural mesothelioma 95
Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells 94
Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1 93
Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2. 90
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms 89
Expression of alternatively spliced human T-cell leukemia virus type 1 mRNAs is influenced by mitosis and by a novel cis-acting regulatory sequence 89
Fine tuning of the temporal expression of HTLV-1 and HTLV-2. 87
A preclinical model for the ATLL lymphoma subtype with insights into the role of microenvironment in HTLV-1-mediated lymphomagenesis 84
Expression of miR-34a in T-cells infected by human T-lymphotropic virus 1 81
Synergistic antitumor activity of recombinant human Apo2L/Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma 76
Converging Strategies in Expression of Human Complex Retroviruses 74
Liquid biopsy in malignant pleural mesothelioma: State of the art, pitfalls, and perspectives 74
Functional analyses of P13II, a mitochondrial protein of human T-cell leukemia virus type-1 57
HTLV-1 regulatory mechanisms: novel testable hypotheses from modeling HTLV-1 expression data 55
Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA 51
Post-transcriptional regulation of HTLV gene expression: Rex to the rescue 49
Prognostic stratification of bladder cancer patients with a MicroRNA-based approach 43
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters 38
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets 5
Totale 2.134
Categoria #
all - tutte 7.584
article - articoli 6.784
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 317
Totale 14.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019175 0 0 0 0 0 0 0 0 0 35 72 68
2019/2020519 63 18 6 50 47 38 50 62 69 54 34 28
2020/2021304 15 34 13 24 5 13 25 28 47 27 35 38
2021/2022430 48 47 33 17 19 86 18 33 11 24 27 67
2022/2023253 44 24 12 25 54 34 0 13 31 0 12 4
2023/2024143 4 27 22 18 15 29 14 7 2 5 0 0
Totale 2.134